Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid
暂无分享,去创建一个
Hesham S. Al-Sallami | H. Al‐Salami | A. Mooranian | M. Majimbi | J. Mamo | E. Eden | P. Galettis | V. Lam | R. Takechi | E. Brook
[1] H. Al‐Salami,et al. Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations , 2020, Pharmaceutics.
[2] H. Al‐Salami,et al. Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies , 2020, Expert opinion on drug delivery.
[3] H. Al‐Salami,et al. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies , 2020, Scientific Reports.
[4] Hesham S. Al-Sallami,et al. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study , 2020, Scientific Reports.
[5] I. McGregor,et al. Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome. , 2019, Journal of natural products.
[6] Hesham S. Al-Sallami,et al. Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice. , 2019, Therapeutic delivery.
[7] Xiangdong Li,et al. Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model. , 2019, Environmental toxicology and pharmacology.
[8] S. O'Sullivan,et al. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans , 2018, Front. Pharmacol..
[9] N. Pavlović,et al. Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles , 2018, Front. Pharmacol..
[10] H. Al‐Salami,et al. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. , 2018, Therapeutic delivery.
[11] S. Oliaro-Bosso,et al. Cannabinoid Delivery Systems for Pain and Inflammation Treatment , 2018, Molecules.
[12] M. Kaur,et al. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies , 2018, Cardiovascular Diabetology.
[13] Sangeeta Rao,et al. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. , 2018, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[14] F. Grotenhermen,et al. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies , 2017, Cannabis and cannabinoid research.
[15] Michael Bazelot,et al. Molecular Targets of Cannabidiol in Neurological Disorders , 2015, Neurotherapeutics.
[16] P. Rakesh,et al. Alginate Beads Prepared by Ionotropic Gelation Technique: Formulation Design , 2015 .
[17] Hesham S. Al-Sallami,et al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study , 2014, Drug design, development and therapy.
[18] G. Cabral,et al. Marijuana use and brain immune mechanisms. , 2014, International review of neurobiology.
[19] J. Chiang. Bile acid metabolism and signaling. , 2013, Comprehensive Physiology.
[20] I. McGregor,et al. Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice , 2012, PloS one.
[21] P. Pacher,et al. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. , 2012, The American journal of pathology.
[22] B. Platt,et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour , 2011, Psychopharmacology.
[23] A. M. Martín-Moreno,et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease , 2011, Molecular Pharmacology.
[24] J. Martínez-Orgado,et al. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study , 2011, Journal of Neuroinflammation.
[25] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[26] L. Liaudet,et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. , 2007, American journal of physiology. Heart and circulatory physiology.
[27] L. Chan,et al. Microencapsulation of oils using sodium alginate. , 2000, Journal of microencapsulation.
[28] M. Feldmann,et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.